K901485

Substantially Equivalent

ENZYGNOST ANTI-CMV/IGG + IGM

Applicant: Behring Diagnostics, Inc.
Product code: LFZ
Advisory panel: Microbiology
Date received: 1990-03-29
Decision date: 1991-05-20
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Somerville, NJ, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.